The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Comparative Study on the Inhibitory Effect of Caffeic and Chlorogenic Acids on Key Enzymes Linked to Alzheimer’s Disease and Some Pro-oxidant Induced Oxidative Stress in Rats’ Brain-In Vitro
Abstract
This study sought to investigate and compare the interaction of caffeic acid and chlorogenic acid on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), and some pro-oxidants (FeSO(4), sodium nitroprusside and quinolinic acid) induced oxidative stress in rat brain in vitro. The result revealed that caffeic acid and chlorogenic acid inhibited AChE and BChE activities in dose-dependent manner; however, caffeic acid had a higher inhibitory effect on AChE and BChE activities than chlorogenic acid. Combination of the phenolic acids inhibited AChE and BChE activities antagonistically. Furthermore, pro-oxidants such as, FeSO(4), sodium nitroprusside and quinolinic acid caused increase in the malondialdehyde (MDA) contents of the brain which was significantly decreased dose-dependently by the phenolic acids. Inhibition of AChE and BChE activities slows down acetylcholine and butyrylcholine breakdown in the brain. Therefore, one possible mechanism through which the phenolic acids exert their neuroprotective properties is by inhibiting AChE and BChE activities as well as preventing oxidative stress-induced neurodegeneration. However, esterification of caffeic acid with quinic acid producing chlorogenic acid affects these neuroprotective properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is suggested that the fraction of phenolic compounds, consisting mainly of caffeic acid (CA), quinic acid (QA), and the chlorogenic acids family, are the main compounds responsible for these properties [145,146,147,148,149,150,151].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [150]
In the citing paper
“Results showed that QA had greater inhibition potential than CQA, concluding that these bioactive molecules can exert neuroprotective properties through the inhibition of AchE and BuChe, suggesting a possible mechanism that slows the ACh and butyrylcholine hydrolysis in the brain [150].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [150]
In the citing paper
“Results showed that QA had greater inhibition potential than CQA, concluding that these bioactive molecules can exert neuroprotective properties through the inhibition of AchE and BuChe, suggesting a possible mechanism that slows the ACh and butyrylcholine hydrolysis in the brain [150].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [150]
Citations
Cites
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
Ohkawa, H., Ohishi, N., & Yagi, K. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90738-3 · Cited by 29,746
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,221
Antioxidant activity applying an improved ABTS radical cation decolorization assay
Re, R., Pellegrini, N., Proteggente, A. R., Pannala, A. S., Yang, M. H., & Rice-Evans, C. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00315-3 · Cited by 26,986
Structure-antioxidant activity relationships of flavonoids and phenolic acids
Rice-Evans, C. A., Miller, N. J., & Paganga, G. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02227-9 · Cited by 9,085
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013
Chlorogenic Acid and Caffeic Acid Are Absorbed in Humans
Olthof, M. R., Katan, M. B., & Hollman, P. C. H. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.1.66 · Cited by 975
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751
Ferreira, A., Proença, C., Serralheiro, M. L. M., & Araújo, M. E. M. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.04.010 · Cited by 480
Alzheimer’s disease pathogenesis and therapeutic interventions
Parihar, M. S., & Hemnani, T. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2003.12.007 · Cited by 441
Kwon, S.-H., Lee, H.-K., Kim, J.-A., Hong, S.-I., Kim, H.-C., Jo, T.-H., Park, Y.-I., Lee, C.-K., Kim, Y.-B., Lee, S.-Y., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.001 · Cited by 437
Research works printed but not linked: 1
- Arnold SE, Kumar A (1993) Reversible dementias. Med Clin North Am 77(215):230
Cited by
Sorted by citations
Items 301–333 of 333
Redox impairment in affective disorders and therapeutic potential of phenolic bioactive compounds
Bertollo, A. G., da Silva, G. B., da Cunha, I. C. E., Bagatini, M. D., & Ignácio, Z. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00006-3 · Cited by 1
Chebchoub, S., Kabouche, Z., Bellouche, D., & Kabouche, A. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2373958 · Cited by 1
Antiaris africana aqueous extract inhibits chronic demyelination and seizures in mice
Amoah, R., Danquah, J., & Mante, P. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34296 · Cited by 1
Chlorogenic acid in energy metabolism on efficacy and mechanisms of action
Li, X., & Jia, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13868-3.00055-7 · Cited by 1
Fierascu, I. C., Fierăscu, I., Fierăscu, R. C., Velescu, B. Ș., & Dinu‐Pîrvu, C. E. (2022) · Springer eBooks · doi:10.1007/978-981-16-4779-6_2 · Cited by 1
Nanotechnological Applications in the Diagnosis and Treatment of Alzheimer’s Dementia
Singh, P. N. D., Mishra, G., Pottoo, F. H., Zeleke, M. M., & Ewunetei, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_22 · Cited by 1
Mechanisms behind the anti-diabetic effects of caffeine in a Type 2 diabetes model of rats.
Reddy, R. (2018) · ResearchSpace (University of KwaZulu-Natal) · Cited by 1
Analysis of the Risk of Profit Lost in papaya farming affected by Yellow Mosaic Disease
Novanda, R. R. (2020) · Journal La Lifesci · doi:10.37899/journallalifesci.v1i5.229
Margetts, G., Kleidonas, S., Zaibi, N. S., Zaibi, M. S., & Edwards, K. D. (2022) · Research Square · doi:10.21203/rs.3.rs-1271841/v1
Woźniak, D., Nawrot-Hadzik, I., Kozłowska, W., Ślusarczyk, S., & Matkowski, A. (2020) · Springer eBooks · doi:10.1007/978-981-13-1745-3_23-1
Potential Neuromodulatory Profile of Phytocompounds in Brain Disorders
Trabace, L. (2017) · MDPI eBooks · doi:10.3390/books978-3-03842-317-1
Roles of Nutraceuticals in Regulating Neurotransmitters in Dementia
Othman, N. F. F., Singh, G. K. S., & Hazalin, N. A. M. N. (2023) · Advances in Pharmacology and Pharmacy · doi:10.13189/app.2023.110201
Abacı, N., Gök, H. N., Aslan, M., & Orhan, İ. E. (2023) · Current Perspectives on Medicinal and Aromatic Plants (CUPMAP) · doi:10.38093/cupmap.1314950
Advances in Pharmacological Mechanism of Eucommia Ulmoides in Treating Parkinson's Disease
(2024) · International Journal of World Medicine · doi:10.38007/ijwm.2024.050106
Jacob, D. E., Nеlson, I. U., & Izah, S. C. (2024) · Reference series in phytochemistry · doi:10.1007/978-3-031-43199-9_59
Classification of Phytochemicals in Plants with Herbal Value
Abdelkhalek, S. T., Shi, J. H., Jin, M. X., Abdelgayed, S. S., & Wang, M. Q. (2024) · Reference series in phytochemistry · doi:10.1007/978-3-031-43199-9_12
Hypertension and effects of coffee-derived analytes caffeic and chlorogenic acids
Agunloye, O. M., Francis, A. O., & Oboh, G. (2024) · Coffee in Health and Disease Prevention · doi:10.1016/b978-0-443-13868-3.00068-5
Tripathi, S., Murtuja, S., Siddique, M. U. M., Ansari, A., & Rakshit, G. (2024) · Journal of the American Nutrition Association · doi:10.1080/27697061.2024.2426558
Cicero, A. F. G., & Micoli, V. D. (2025) · Springer eBooks · doi:10.1007/978-3-031-93459-9_7
Donepezil: cholinesterase inhibitor for the treatment of Alzheimer's disease
Singh, V. K., Rai, S., & Singh, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33885-4.00040-8
Margetts, G., Kleidonas, S., Zaibi, N. S., Zaibi, M. S., & Edwards, K. D. (2022) · Figshare · doi:10.6084/m9.figshare.19759925
Margetts, G., Kleidonas, S., Zaibi, N. S., Zaibi, M. S., & Edwards, K. D. (2022) · Figshare · doi:10.6084/m9.figshare.19759919
Margetts, G., Kleidonas, S., Zaibi, N. S., Zaibi, M. S., & Edwards, K. D. (2022) · Figshare · doi:10.6084/m9.figshare.19759928
Abdelbaset, S., Ayoub, I. M., Mohamed, O. G., Tripathi, A., Eldahshan, O. A., & El‐Kersh, D. M. (2024) · Figshare · doi:10.6084/m9.figshare.26043698
Margetts, G., Kleidonas, S., Zaibi, N. S., Zaibi, M. S., & Edwards, K. D. (2022) · Figshare · doi:10.6084/m9.figshare.19759916
Margetts, G., Kleidonas, S., Zaibi, N. S., Zaibi, M. S., & Edwards, K. D. (2022) · Figshare · doi:10.6084/m9.figshare.19759922
Solmaz, F. Ö. K., Sarıkürkçü, C., & Tepe, B. (2026) · ChemistryOpen · doi:10.1002/open.202500603
Alzheimer’s disease and apitherapy: the therapeutic effect of various honeybee products
Rashwan, E. H., Elashal, M. H., Khalifa, S. A. M., El‐Wahed, A. A. A., Wang, D., Hussein, W. M., Wang, X., Cheng, G., Naggar, Y. A., Wang, H., et al. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2664407
Neuroprotective Effects of Ethiopian Coffee Beans against Hyperglycemia‐induced Brain Injury in Rats
Mohamed, A. I., Olofinsan, K. A., Erukainure, O. L., Ismail, H., & Islam, M. S. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.72054
Salama, A., Mohammed, M. A., & Mohasib, R. M. M. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-026-00768-5
Sisik, B., & Sarıkürkçü, C. (2026) · RSC Advances · doi:10.1039/d6ra04715g
Sharif, S., Naveed, Q., Ghaffar, A., Mustafa, G., Atta, A., Nayila, I., & Malik, H. (2026) · BioScientific Review · doi:10.32350/bsr.82.08
Metadata
- Authors
- Oboh, G., Agunloye, O. M., Akinyemi, A. J., Ademiluyi, A. O., & Adefegha, S. A.
- Affiliations
- Federal University of Technology (NG)
- Corresponding author
- Oboh, Ganiyu
- Akinyemi, Ayodele J.
- Venue
- Neurochemical Research
- Published
- 2012-11-27
- Volume
- 38
- Issue
- 2
- Pages
- 413-419
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W1973733191
- Cited by
- 333
- References
- 42
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 38 · 2023: 39 · 2022: 43 · 2021: 32 · 2020: 37 · 2019: 19 · 2018: 20 · 2017: 25 · 2016: 21 · 2015: 17 · 2014: 7 · 2013: 4
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Keywords
- caffeic acid, chlorogenic acid, phenolic acids, acetylcholinesterase inhibition, butyrylcholinesterase inhibition, Alzheimer's disease, oxidative stress, pro-oxidants, malondialdehyde, neuroprotection, quinolinic acid, sodium nitroprusside, iron sulfate, brain
- MeSH terms
- Acetylcholinesterase, Alzheimer Disease, Animals, Brain, Butyrylcholinesterase, Caffeic Acids, Chlorogenic Acid, Cholinesterase Inhibitors, Male, Rats, Wistar, Reactive Oxygen Species, Oxidative Stress, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
